Skip to content

MAXIMIZE: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MAXIMIZE

BE 0433.126.180
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€21,706
2024 · €23,467-€1,761
Equity
-€40,778
2024 · -€62,484+€21,706
Cash
€3,328
2024 · €351+€2,976
Balance sheet total
€20,065
2024 · €10,470+€9,595

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€6,630

    up €6,630 (+497.8%), from €1,332 to €7,962

  • Cash +€2,976

    up €2,976 (+847.7%), from €351 to €3,328

    mainly Net result for the year (+€21,706) and Tax, wage and social debts (+€7,794)

Equity and liabilities
  • Profit (loss) carried forward +€21,706

    up €21,706 (+30.9%), from -€70,235 to -€48,529

  • Other debts -€21,225

    down €21,225 (-34.6%), from €61,351 to €40,126

  • Tax, wage and social debts +€7,794

    up €7,794 (+73.3%), from €10,635 to €18,430

  • Trade debts +€1,319

    up €1,319 (+136.4%), from €967 to €2,287

Income statement
  • Gross operating margin -€2,484

    down €2,484 (-7.6%), from €32,834 to €30,350

  • Taxes -€441

    down €441 (-5.0%), from €8,820 to €8,379

  • Depreciation -€340

    down €340 (-100.0%), from €340 to €0

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €23,467
Gross operating margin -€2,484
Depreciation +€340
Other operating charges -€2
Financial charges -€56
Taxes +€441
Result 2025 €21,706

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€2,976
Investment €0
Financing €0
Cash 2024 €351
Net result for the year +€21,706
Receivables within one year -€6,630
Deferred charges and accrued income +€12
Trade debts +€1,319
Tax, wage and social debts +€7,794
Other debts -€21,225
Cash 2025 €3,328
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €10,470 €20,065 +€9,595 +91.6%
Fixed assets 21/28 €0 - =
Tangible fixed assets 22/27 €0 - =
Plant, machinery and equipment 23 €0 - =
Current assets 29/58 €10,470 €20,065 +€9,595 +91.6%
Stocks and contracts in progress 3 €8,767 €8,767 = 0.0%
Stocks 30/36 €8,767 €8,767 = 0.0%
Amounts receivable within one year 40/41 €1,332 €7,962 +€6,630 +497.8%
Trade receivables 40 €1,332 €7,962 +€6,630 +497.8%
Cash at bank and in hand 54/58 €351 €3,328 +€2,976 +847.7%
Deferred charges and accrued income 490/1 €19 €8 -€12 -59.6%
Total equity and liabilities 10/49 €10,470 €20,065 +€9,595 +91.6%
Equity 10/15 -€62,484 -€40,778 +€21,706 +34.7%
Contributions 10/11 €6,205 €6,205 = 0.0%
Reserves 13 €1,546 €1,546 = 0.0%
Distributable reserves 133 €1,546 €1,546 = 0.0%
Profit (loss) carried forward 14 -€70,235 -€48,529 +€21,706 +30.9%
Amounts payable 17/49 €72,954 €60,843 -€12,111 -16.6%
Amounts payable within one year 42/48 €72,954 €60,843 -€12,111 -16.6%
Trade debts 44 €967 €2,287 +€1,319 +136.4%
Suppliers 440/4 €967 €2,287 +€1,319 +136.4%
Taxes, remuneration and social security 45 €10,635 €18,430 +€7,794 +73.3%
Taxes 450/3 €10,635 €18,430 +€7,794 +73.3%
Other amounts payable 47/48 €61,351 €40,126 -€21,225 -34.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €340 €0 -€340 -100.0%
Other operating charges 640/8 €118 €120 +€2 +1.7%
Gross operating margin 9900 €32,834 €30,350 -€2,484 -7.6%
Operating profit (loss) 9901 €32,377 €30,230 -€2,146 -6.6%
Financial income 75/76B €0 - =
Recurring financial income 75 €0 - =
Financial charges 65/66B €89 €145 +€56 +62.9%
Recurring financial charges 65 €89 €145 +€56 +62.9%
Profit (loss) for the period before taxes 9903 €32,287 €30,085 -€2,202 -6.8%
Income taxes 67/77 €8,820 €8,379 -€441 -5.0%
Profit (loss) for the period 9904 €23,467 €21,706 -€1,761 -7.5%
Profit (loss) for the period to be appropriated 9905 €23,467 €21,706 -€1,761 -7.5%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.